Published in Blood Rev on March 01, 1988
Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+, CD3+CD4-CD8- and CD3-CD4-CD8- lymphocytes. Clin Exp Immunol (1990) 0.95
Regulation of granulocyte and macrophage populations of murine bone marrow cells by G-CSF and CD137 protein. PLoS One (2010) 0.91
Characterization of circulating CD4+ CD8+ lymphocytes in healthy individuals prompted by identification of a blood donor with a markedly elevated level of CD4+ CD8+ lymphocytes. Clin Diagn Lab Immunol (1994) 0.82
Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific. Immunology (1991) 0.75
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49
Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26
The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18
Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
B cell life span: a review. Immunol Cell Biol (1997) 1.15
Suppressor cells in humoral immunity and tolerance. Br Med Bull (1976) 1.14
Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14
Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur J Immunol (1997) 1.14
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
Cell interactions in the immune response in vitro. I. Metabolic activities of T cells in a collaborative antibody response. Eur J Immunol (1972) 1.13
B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12
The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12
Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11
Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10
Suppressor T-cell memory. Nature (1978) 1.10
Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A (1991) 1.09
Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol (1980) 1.09
Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09
Post-mammoplasty connective tissue disease. Arthritis Rheum (1982) 1.08
Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Clin Exp Immunol (1988) 1.05
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04
Mechanisms of tolerance to self. Curr Opin Immunol (1996) 1.04
Individuals from different populations identify multiple and diverse T-cell determinants on mycobacterial HSP70. Scand J Immunol (1994) 1.03
Suppressor T cells in tolerance to non-self and self antigens. Cold Spring Harb Symp Quant Biol (1977) 1.03
Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature (1979) 1.03
T cell reactivity to the purified mycobacterial antigens p65 and p70 in leprosy patients and their household contacts. Clin Exp Immunol (1990) 1.01
Selective cytotoxicity of anti-kappa serum for B lymphocytes. Nat New Biol (1972) 0.98
HLA-DW2, viral immunity and family studies in multiple sclerosis. J Neurol Sci (1977) 0.97
Complementary relationship between repetitive sequences in the SV40 early gene pre-promoter enhancing region and big-T antigen splice junction exons. J Theor Biol (1984) 0.96
Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol (1980) 0.95
Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med (1998) 0.95
The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect Immun (1992) 0.92
Total lipodystrophy--a report of a case with peripheral neuropathy and glomerulonephritis. Aust N Z J Med (1983) 0.92
"Sneaking through": a T-cell-dependent phenomenon. Br J Cancer (1981) 0.92
T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction. Eur J Immunol (1978) 0.92
Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus. Part II. Identification of the major IgE-binding antigens by crossed radioimmunoelectrophoresis. J Allergy Clin Immunol (1984) 0.91
Induction of memory and effector suppressor T cells by perinatal exposure to antigen. Eur J Immunol (1984) 0.91
A role for suppressor T cells in induction of self-tolerance. Proc Natl Acad Sci U S A (1985) 0.91
Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol (1984) 0.91
Immune function in aged mice. V. Role of suppressor cells. J Immunol (1980) 0.90
T cell clones from a non-leprosy exposed subject recognize the Mycobacterium leprae 18-kD protein. Clin Exp Immunol (1995) 0.89
Use of phenolic glycolipid 1 for serodiagnosis of leprosy in a high prevalence village in Papua New Guinea. Trans R Soc Trop Med Hyg (1987) 0.88
Detection of membrane-associated antigens on lymphoid cells by antibody coupled to staphylococcal protein A. J Immunol (1975) 0.88
Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (1988) 0.88
Immune system of the gastrointestinal tract. Int Rev Physiol (1983) 0.87
Subclinical infection with Mycobacterium leprae--a problem for leprosy control strategies. Trans R Soc Trop Med Hyg (1993) 0.87
Identification of biological false positives in anti-HIV antibody tests. AIDS (1987) 0.86
Hen egg-white lysozyme-specific T cells elicited in hen egg-white lysozyme-transgenic mice retain an imprint of self-tolerance. J Immunol (1993) 0.86
Transfer factor in treatment of multiple sclerosis. Lancet (1980) 0.86
Scleroderma in carcinoma. Med J Aust (1966) 0.86
Isolation and structural characteristics of a monoclonal antibody-defined cross-reactive phospholipid antigen from Mycobacterium tuberculosis and Mycobacterium leprae. J Biol Chem (1991) 0.86
Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. Infect Immun (1997) 0.85
B-cell activation versus tolerance--the central role of immunoglobulin receptor engagement and T-cell help. Int Rev Immunol (1997) 0.85
Familial hypersensitivity pneumonitis. Am J Med (1975) 0.84
A receptor for antibody on B lymphocytes. III. Relationship to immunoglobulin and ia determinants. Int Arch Allergy Appl Immunol (1976) 0.84
Whither the anergic B-cell? Autoimmunity (1994) 0.84
Rescue of self-reactive B cells by provision of T cell help in vivo. Eur J Immunol (1998) 0.84
Characterization of the functional properties of the 70-kDa protein of Mycobacterium bovis. J Biol Chem (1991) 0.83
Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen. Clin Exp Immunol (1993) 0.83
Immunopurification of radiolabelled antigens of Mycobacterium leprae and Mycobacterium bovis (bacillus Calmette-Guerin) with monoclonal antibodies. Scand J Immunol (1987) 0.83
The successful treatment of primary amyloidosis with intermittent chemotherapy. Aust N Z J Med (1978) 0.83
Loss of secretion in mouse-human hybrids need not be due to the loss of a structural gene. J Exp Med (1982) 0.82
Current status of interferon therapy. Med J Aust (1984) 0.82
Standardization of antigen E in ragweed pollen extracts using a monoclonal antibody-based enzyme immunoassay. J Allergy Clin Immunol (1983) 0.82
Analysis of allergen-specific IgE responses in 341 allergic patients. Associations between allergens and between allergen groups and clinical diagnoses. Aust N Z J Med (1985) 0.81